Literature DB >> 16126920

Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations.

Mohamad E Allaf1, Ioannis M Varkarakis, Sam B Bhayani, Takeshi Inagaki, Louis R Kavoussi, Stephen B Solomon.   

Abstract

PURPOSE: To retrospectively compare the pain control requirements of patients undergoing computed tomography (CT)-guided percutaneous radiofrequency (RF) ablation with those of patients undergoing CT-guided percutaneous cryoablation of small (< or = 4-cm) renal tumors.
MATERIALS AND METHODS: The study was HIPAA compliant and received institutional review board exemption; informed consent was not required. Medical and procedure records of patients who underwent RF ablation and cryoablation of renal tumors from June 19, 2003, to February 28, 2004, were retrospectively reviewed for clinical data, tumor characteristics, and anesthesia information. During the study period, 10 men (mean age, 66.5 years) underwent cryoablation of 11 renal lesions, and 14 patients (11 men, four women; mean age, 68.1 years) underwent RF ablation of 15 renal tumors. Analgesic and sedative requirements during the procedure were compared. Standard anesthesia consisted of 5 mL of 1% lidocaine injected locally, and conscious sedation consisted of 50 microg of fentanyl and 1 mg of midazolam administered intravenously. The Fisher exact test and Student t test were used to compare clinical factors and drug requirements between the two groups.
RESULTS: There was no difference in terms of patient demographics, tumor diameter, or distribution of central versus noncentral lesions between the two groups. Cryoablation was associated with a significantly lower dose of fentanyl (165.0 microg [RF group] vs 75.0 microg [cryoablation group]; P < .001) and midazolam (2.9 mg [RF group] vs 1.6 mg [cryoablation group]; P = .026). In the RF group, one patient required general anesthesia, one patient required supplemental narcotics (5 mg of oxycodone) and sedatives (1 mg lorezapam), and one patient became apneic for a brief interval after receiving additional narcotics for pain during the procedure. An additional RF session was terminated early in one patient because of pain, and further medication could not be administered owing to bradycardia. No patients in the cryoablation group required any additional or alternate anesthetics.
CONCLUSION: Image-guided percutaneous cryoablation of small (< or = 4-cm) renal lesions appears to require less analgesia than RF ablation. Prospective trials with validated pain scales are needed to examine this further. RSNA, 2005

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126920     DOI: 10.1148/radiol.2371040829

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  34 in total

Review 1.  Management and prevention of renal ablative therapy complications.

Authors:  G Igor Pinkhasov; Jay D Raman
Journal:  World J Urol       Date:  2010-04-10       Impact factor: 4.226

2.  Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation.

Authors:  Hyun J Bang; Peter J Littrup; Dylan J Goodrich; Brandt P Currier; Hussein D Aoun; Lance K Heilbrun; Ulka Vaishampayan; Barbara Adam; Allen C Goodman
Journal:  J Vasc Interv Radiol       Date:  2012-04-25       Impact factor: 3.464

3.  Image-guided nerve cryoablation for post-thoracotomy pain syndrome.

Authors:  Yilun Koethe; Andrew J Mannes; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2013-08-17       Impact factor: 2.740

4.  Combined magnetic resonance imaging and optical surgical navigation system guidance of percutaneous liver cryoablation in a porcine model.

Authors:  Kang Zhou; Zhuoli Zhang; Matteo Figini; Junjie Shangguan; Yining Wang; Haifeng Shi; Yumei Li; Zhengyu Jin; Jie Pan
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

5.  Percutaneous cryoablation in early stage hepatocellular carcinoma: analysis of local tumor progression factors.

Authors:  Dong Kyu Kim; Kichang Han; Jong Yun Won; Gyoung Min Kim; Joon Ho Kwon; Man Deuk Kim
Journal:  Diagn Interv Radiol       Date:  2020-03       Impact factor: 2.630

Review 6.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

Review 7.  Interventional radiology of the adrenal glands: current status.

Authors:  Anna Maria Ierardi; Mario Petrillo; Francesca Patella; Pierpaolo Biondetti; Enrico Maria Fumarola; Salvatore Alessio Angileri; Filippo Pesapane; Antonio Pinto; Gianlorenzo Dionigi; Gianpaolo Carrafiello
Journal:  Gland Surg       Date:  2018-04

8.  CT-guided percutaneous cryoablation of central lung tumors.

Authors:  Errol Colak; Servet Tatlı; Paul B Shyn; Kemal Tuncalı; Stuart G Silverman
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

9.  MR imaging-guided interventions in the genitourinary tract: an evolving concept.

Authors:  Fiona M Fennessy; Kemal Tuncali; Paul R Morrison; Clare M Tempany
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-02       Impact factor: 2.266

Review 10.  Quality improvement guidelines for bone tumour management.

Authors:  A Gangi; G Tsoumakidou; X Buy; E Quoix
Journal:  Cardiovasc Intervent Radiol       Date:  2010-02-12       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.